MAIA•benzinga•
MAIA Biotechnology Announces Design For Expansion Of THIO-101 Phase 2 Trial In Advanced Non-Small Cell Lung Cancer; To Enroll Patients In The U.S. And Select Countries In Europe And Asia
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 26, 2025 by benzinga